Joint preserving implant intended to reduce thumb carpometacarpal joint pain while maintaining pinch strength, range of motion and dexterity
| FRANKLIN, Mass., July 10, 2019 /PRNewswire/ -- ArthroSurface®, Inc., a global leader in joint preservation technology, today announced the launch of its SpeedSpiral™ CMC System. Designed for patients suffering from osteoarthritis (OA) in the thumb, the SpeedSpiral carpometacarpal (CMC) implant is the first to replace the arthritic bone with a structurally sound, load-bearing biologic implant.
In the United States, hand osteoarthritis is second in prevalence only to knee arthritis and thumb CMC OA is a common and disabling degenerative disease that affects up to 33 percent of women and 11 percent of men in their 50s and 60s. The thumb is critical to hand function with nearly all the basic activities of daily living requiring precision pinching and grasping. Loss of thumb function due to CMC OA causes a 40 to 50 percent impairment to the upper extremity, severely impacting a patient’s quality of life. “The joint at the base of the thumb is the most mobile in the hand, allowing us to effortlessly perform the most basic tasks like writing, eating and getting dressed,” said Steve Ek, CEO of Arthrosurface. “But over time, all of the movement and pressure at the thumb joint can cause ‘wear and tear,’ resulting in joint deterioration and arthritis for many individuals. Arthrosurface has been searching for the most effective surgical treatment for addressing this joint pathology for over a decade. With the guidance of our surgeon design team, I’m convinced we now have it.” The SpeedSpiral CMC System utilizes a pre-shaped, dense, strong and flexible allograft implant to treat thumb CMC joint pain and/or instability caused by OA. It is designed to supplement and support the FCR tendon and/or the capsuloligamentous structures at the thumb while also minimizing operating room time. The implant shape diminishes the risk of metacarpal subsidence that is common to other autograft-only procedures and avoids thumb shortening. “I have been very impressed with the maintenance of post-operative thumb metacarpal height by the SpeedSpiral implant, which is critical to overall pinch strength in these patients long-term,” said Arnold-Peter C. Weiss, M.D., Chief - Hand, Upper Extremity & Microvascular Surgery, Vice Chairman & Professor of Orthopaedics, Warren Alpert Medical School, Brown University. “Having a forgiving yet stable fulcrum for the thumb enhances overall strength outcomes, which is the main issue facing alternative soft tissue reconstructive procedures today.” To learn more about Arthrosurface’s SpeedSpiral CMC System, click here. About Arthrosurface®, Inc. Arthrosurface®, Inc. is a global leader in joint preservation technology, manufacturing less invasive joint replacements that are clinically proven to help patients stay active by increasing range of motion and reducing pain. The company’s product portfolio features more than 150 different surface implant curvatures for the knee, shoulder, hip, ankle, wrist and toe that are designed to treat upper and lower extremity orthopedic conditions caused by trauma, injury and arthritic disease. More than 100,000 patients have been treated with Arthrosurface implants since the company was founded in 2002. Arthrosurface markets and distributes its products in the United States and around the world, with more than 5,000 surgeons currently using Arthrosurface products in more than 25 countries. For more information, please visit our website at www.arthrosurface.com.
SOURCE Arthrosurface, Inc. |
View original content to download multimedia:
